One Homepage,Ten Pages Behind It

Template C’s homepage sections are now pages of their own, joined by the Science, Providers and Resources pages from the previous vesaliuslabs.com. Pin any page or row on the review board to change it.

The Structure

/

Home

  • Scroll hero · Mission · Quality summary · Science · Providers · Leadership · News · Contact

Template C homepage, shortened: each section now ends in a link to its own page.

/about/

About

  • Mission statement and cards
  • Our founding
  • Why “Vesalius”
  • What we do, how, why it matters
  • Quote

Template C Mission + previous About page

/science/

Science

  • Overview: five ways in
  • What Are Peptides
  • Peptide Platform
  • Delivery Formats
  • Muse Cells

Previous Science section (four pages) plus a Muse cells page from Samara

/quality/

Quality + Documentation

  • US outline video
  • Origin, Testing, Records, Access
  • Our standards
  • Certificate requests

Template C Quality + previous Safety & Quality page

/providers/

For Healthcare Providers

  • New and returning providers
  • What providers receive
  • Eligibility
  • Provider account intake

Template C Providers + previous Providers and Become a Partner pages

/leadership/

Leadership

  • Officers & Management
  • Directors
  • Scientific Advisors
  • Strategic Advisors
  • Biographies

Template C Leadership + previous Team bios

/resources/

News & Resources

  • Press releases
  • Conferences & summits

Template C News + previous Resources page

/contact/

Contact

  • Contact channels
  • Three-step HubSpot form

Template C Contact

/legal/

Legal

  • Privacy Policy
  • FDA Disclaimer

Previous legal pages, word for word

Navigation

Header and Menu

  • Six links, Science dropdown
  • Request Provider Information
  • Full-screen Menu on phones and tablets

Menu style follows MuseCell and Dezawa

Where the Words Came From

Copy from the previous site is carried over as it was, with the changes below. Everything is ready for your edits.

PageSourceChanged or left out
Home, Quality, Providers, ContactTemplate C (the approved current homepage wording)Unchanged, except the contact form intro now reads “Provider, partnership and media inquiries” (it said “investor”).
AboutPrevious About page (client copy, June 2026)Left out the “Path to public” timeline (listing and RTO milestones) and the Peptual launch milestone.
Science, What Are Peptides, Peptide Platform, Delivery FormatsPrevious Science pagesWord for word, with dashes replaced by commas or colons.
Quality: Our StandardsPrevious Safety & Quality pageLeft out the line “A public company cannot stand on grey-market supply.”
ProvidersPrevious Providers and Become a Partner pagesThe intake button opens the contact form (Provider Support). The old site used a separate HubSpot provider form.
LeadershipCurrent roster (live homepage) + previous team biosBios exist for 15 people; none yet for the directors or the newer officers. Chris Cooper’s bio dropped (no longer listed).
News & ResourcesTemplate C releases + previous Resources pageLeft out the Sweet Earth and listing releases, the Peptual endorsement release and the MuseCell manufacturing release.
Why Vesalius, Investors, Forward-Looking StatementsPrevious siteNot carried over: investor content now belongs on the separate investor site.

Questions for Samara

Peptual name

The October 29 Celularity release title names Peptual®. Keep the official title, or list it without the brand name?

Co-founders

About still credits Dr. Matt Cook and Jennifer Benson as co-founders. Is that still the wording leadership wants?

Headshots and bios

Your shared document with headshots and bios will replace the monograms and fill in missing bios once consents are signed.

Animations

The scroll hero stays on the homepage. Should any of the other motion move to a page of its own, as you mentioned on the call?

Older releases

Bring back any of the 2025 releases (Wisp, advisor appointments) with full release pages?

Palette

Decided November 6: gold with blue. The black and gold option and its switch have been removed.

Disclaimer: The information provided on this website is intended for general educational and informational purposes only. Vesalius Longevity Labs provides information relating to peptide science, longevity, wellness, metabolic health, and emerging areas of medical research.

FDA Approval & Investigational Therapies: Not all peptides, compounds, medications, or therapies discussed or referenced on this website are approved by the U.S. Food and Drug Administration (FDA). Certain compounds may be investigational, have limited clinical evidence, or lack established long-term safety and efficacy data. References to scientific research, emerging therapies, or potential health benefits are provided for informational purposes and should not be interpreted as claims of FDA approval, established clinical effectiveness, or guaranteed therapeutic outcomes. Where legally permitted, certain medications may be compounded by appropriately licensed pharmacies in accordance with applicable federal and state laws. Compounded medications are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before marketing in the same manner as FDA-approved medications. Read the full disclaimer.